Centene Corporation
Centene Reports Q2 2026 Financial Results and Board Changes
Summary
Centene Corporation announced its financial results for the second quarter of 2026, reporting GAAP diluted earnings per share of $2.19 and adjusted diluted earnings per share of $2.51. The company also increased its full-year 2026 guidance for GAAP diluted EPS to greater than $3.11 and for adjusted diluted EPS to greater than $4.80. Additionally, Director Kenneth Burdick resigned from the Board, and Paul Diaz was appointed as a new director, effective July 28, 2026.
Profitelligence Alerts
Get alerts for CNC
Be first to know when Centene Corporation files with the SEC.
Filing Categories
Advertisement
About Centene Corporation
Centene Corporation is a diversified healthcare enterprise providing a comprehensive range of managed care services to government-sponsored healthcare programs. Specializing in serving uninsured and underinsured populations, Centene offers health plans, benefits management, and other related services. It operates through two primary segments: Managed Care and Specialty Services. The Managed Care segment provides health plan coverage to individuals through Medicaid, Medicare Advantage, and the Health Insurance Marketplace, impacting millions of lives across the United States. Meanwhile, the Specialty Services segment enhances healthcare quality and affordability through offerings such as pharmacy solutions, behavioral health, and optometry services. Founded in 1984 and headquartered in St. Louis, Missouri, Centene plays a significant role in the healthcare sector by addressing accessibility and cost challenges, thereby shaping market trends and influencing policy developments. As a major participant in the managed care industry, Centene is crucial for promoting coordinated care and improving health outcomes for vulnerable populations.
Official SEC Documents
Advertisement